Logo image of ABO.BR

ABO GROUP ENVIRONMENT (ABO.BR) Stock Fundamental Analysis

EBR:ABO - Euronext Brussels - BE0974278104 - Common Stock - Currency: EUR

6.05  0 (0%)

Fundamental Rating

4

Taking everything into account, ABO scores 4 out of 10 in our fundamental rating. ABO was compared to 39 industry peers in the Commercial Services & Supplies industry. ABO has only an average score on both its financial health and profitability. ABO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ABO had positive earnings in the past year.
In the past year ABO had a positive cash flow from operations.
In the past 5 years ABO has always been profitable.
ABO had a positive operating cash flow in each of the past 5 years.
ABO.BR Yearly Net Income VS EBIT VS OCF VS FCFABO.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

1.2 Ratios

ABO's Return On Assets of 1.93% is in line compared to the rest of the industry. ABO outperforms 51.28% of its industry peers.
The Return On Equity of ABO (7.34%) is comparable to the rest of the industry.
ABO's Return On Invested Capital of 6.90% is fine compared to the rest of the industry. ABO outperforms 71.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABO is in line with the industry average of 7.40%.
The last Return On Invested Capital (6.90%) for ABO is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.93%
ROE 7.34%
ROIC 6.9%
ROA(3y)2.67%
ROA(5y)2.95%
ROE(3y)9.24%
ROE(5y)10%
ROIC(3y)6.75%
ROIC(5y)6.66%
ABO.BR Yearly ROA, ROE, ROICABO.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ABO has a Profit Margin (1.98%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ABO has declined.
Looking at the Operating Margin, with a value of 5.11%, ABO is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
ABO's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 82.71%, ABO belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
In the last couple of years the Gross Margin of ABO has declined.
Industry RankSector Rank
OM 5.11%
PM (TTM) 1.98%
GM 82.71%
OM growth 3Y6%
OM growth 5Y-3.01%
PM growth 3Y-14.39%
PM growth 5Y-11.63%
GM growth 3Y-2.08%
GM growth 5Y-1.79%
ABO.BR Yearly Profit, Operating, Gross MarginsABO.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABO is creating some value.
The number of shares outstanding for ABO remains at a similar level compared to 1 year ago.
The number of shares outstanding for ABO remains at a similar level compared to 5 years ago.
ABO has a worse debt/assets ratio than last year.
ABO.BR Yearly Shares OutstandingABO.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ABO.BR Yearly Total Debt VS Total AssetsABO.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.05 indicates that ABO is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.05, ABO is doing good in the industry, outperforming 61.54% of the companies in the same industry.
The Debt to FCF ratio of ABO is 12.48, which is on the high side as it means it would take ABO, 12.48 years of fcf income to pay off all of its debts.
ABO has a Debt to FCF ratio (12.48) which is in line with its industry peers.
ABO has a Debt/Equity ratio of 0.63. This is a neutral value indicating ABO is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, ABO perfoms like the industry average, outperforming 58.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.48
Altman-Z 2.05
ROIC/WACC1.14
WACC6.06%
ABO.BR Yearly LT Debt VS Equity VS FCFABO.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.3 Liquidity

ABO has a Current Ratio of 1.09. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.09, ABO is doing worse than 64.10% of the companies in the same industry.
ABO has a Quick Ratio of 1.06. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
ABO's Quick ratio of 1.06 is in line compared to the rest of the industry. ABO outperforms 53.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.06
ABO.BR Yearly Current Assets VS Current LiabilitesABO.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

The earnings per share for ABO have decreased strongly by -24.90% in the last year.
ABO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.48% yearly.
Looking at the last year, ABO shows a quite strong growth in Revenue. The Revenue has grown by 14.63% in the last year.
Measured over the past years, ABO shows a quite strong growth in Revenue. The Revenue has been growing by 14.83% on average per year.
EPS 1Y (TTM)-24.9%
EPS 3Y-1.79%
EPS 5Y1.48%
EPS Q2Q%-22.64%
Revenue 1Y (TTM)14.63%
Revenue growth 3Y14.71%
Revenue growth 5Y14.83%
Sales Q2Q%14.96%

3.2 Future

ABO is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.46% yearly.
Based on estimates for the next years, ABO will show a quite strong growth in Revenue. The Revenue will grow by 14.99% on average per year.
EPS Next YN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y23.53%
Revenue Next 3Y14.99%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABO.BR Yearly Revenue VS EstimatesABO.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 20M 40M 60M 80M 100M
ABO.BR Yearly EPS VS EstimatesABO.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2026 2027 0.1 0.2 0.3 0.4 0.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.61, the valuation of ABO can be described as expensive.
ABO's Price/Earnings ratio is in line with the industry average.
ABO is valuated rather expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.61
Fwd PE N/A
ABO.BR Price Earnings VS Forward Price EarningsABO.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

64.10% of the companies in the same industry are more expensive than ABO, based on the Enterprise Value to EBITDA ratio.
ABO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 20.93
EV/EBITDA 7.01
ABO.BR Per share dataABO.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of ABO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)22.73
EPS Next 2Y5.71%
EPS Next 3Y-0.46%

2

5. Dividend

5.1 Amount

ABO has a Yearly Dividend Yield of 1.54%.
Compared to an average industry Dividend Yield of 4.32, ABO has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.37, ABO is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
ABO.BR Yearly Income VS Free CF VS DividendABO.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

ABO GROUP ENVIRONMENT

EBR:ABO (7/11/2025, 7:00:00 PM)

6.05

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners85.24%
Ins Owner ChangeN/A
Market Cap63.95M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 33.61
Fwd PE N/A
P/S 0.67
P/FCF 20.93
P/OCF 8.25
P/B 2.47
P/tB 4.24
EV/EBITDA 7.01
EPS(TTM)0.18
EY2.98%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.29
FCFY4.78%
OCF(TTM)0.73
OCFY12.12%
SpS9.07
BVpS2.44
TBVpS1.43
PEG (NY)N/A
PEG (5Y)22.73
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 7.34%
ROCE 9.97%
ROIC 6.9%
ROICexc 9.5%
ROICexgc 13.6%
OM 5.11%
PM (TTM) 1.98%
GM 82.71%
FCFM 3.19%
ROA(3y)2.67%
ROA(5y)2.95%
ROE(3y)9.24%
ROE(5y)10%
ROIC(3y)6.75%
ROIC(5y)6.66%
ROICexc(3y)10.47%
ROICexc(5y)11.44%
ROICexgc(3y)13.66%
ROICexgc(5y)14.41%
ROCE(3y)9.75%
ROCE(5y)9.61%
ROICexcg growth 3Y3.29%
ROICexcg growth 5Y5.77%
ROICexc growth 3Y-2.3%
ROICexc growth 5Y0.98%
OM growth 3Y6%
OM growth 5Y-3.01%
PM growth 3Y-14.39%
PM growth 5Y-11.63%
GM growth 3Y-2.08%
GM growth 5Y-1.79%
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 12.48
Debt/EBITDA 1.29
Cap/Depr 60.56%
Cap/Sales 4.9%
Interest Coverage 3.48
Cash Conversion 61.27%
Profit Quality 161.04%
Current Ratio 1.09
Quick Ratio 1.06
Altman-Z 2.05
F-Score6
WACC6.06%
ROIC/WACC1.14
Cap/Depr(3y)61.35%
Cap/Depr(5y)64.84%
Cap/Sales(3y)4.92%
Cap/Sales(5y)5.25%
Profit Quality(3y)155.26%
Profit Quality(5y)177.18%
High Growth Momentum
Growth
EPS 1Y (TTM)-24.9%
EPS 3Y-1.79%
EPS 5Y1.48%
EPS Q2Q%-22.64%
EPS Next YN/A
EPS Next 2Y5.71%
EPS Next 3Y-0.46%
EPS Next 5YN/A
Revenue 1Y (TTM)14.63%
Revenue growth 3Y14.71%
Revenue growth 5Y14.83%
Sales Q2Q%14.96%
Revenue Next YearN/A
Revenue Next 2Y23.53%
Revenue Next 3Y14.99%
Revenue Next 5YN/A
EBIT growth 1Y4.44%
EBIT growth 3Y21.59%
EBIT growth 5Y11.37%
EBIT Next YearN/A
EBIT Next 3Y34.11%
EBIT Next 5YN/A
FCF growth 1Y-19.09%
FCF growth 3Y9.03%
FCF growth 5Y-6.88%
OCF growth 1Y0.65%
OCF growth 3Y4.61%
OCF growth 5Y4.02%